An Exploratory Study of Iliac Artery Branch Stent for Internal Iliac Artery Reconstruction in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair
Key facts
- Where
- Shanghai, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06162273, who can take part
Where in China
- RenJi HospitalShanghai, ChinaContact: Guanhua Xue, M.D.No longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- RenJi Hospital
- Trial code
- NCT06162273
- Record updated
- 8 December 2023
- Original description
The purpose of this study is to evaluate the efficacy and safety of IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company in the treatment of abdominal aortic aneurysm/iliac aneurysm reconstruction of internal iliac arteryRead full original descriptionShow less
Comparing the Efficacy and Safety of IBD Stent of Shenzhen Xianjian Company and IBE Stent of American Gore Company for Reconstruction of Internal Iliac Artery in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair
The purpose of this study is to evaluate the efficacy and safety of IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company in the treatment of abdominal aortic aneurysm/iliac aneurysm reconstruction of internal iliac artery
Inclusion: Patients with iliac aneurysms combined with or without abdominal aortic aneurysms and internal iliac arteries reconstructed with iliac branch stents; Male or female ≥18 years old, ≤85 years old; Life expectancy > 2 years; The patient signed the informed consent voluntarily and was able to comply with the treatment plan and complete the follow-up and examination as planned.
Exclusion: Conduct another device or drug study within 1 year of treatment; NYHA Grade IV heart failure; Intercalation, severe calcification, or anchoring area with thrombosis; Systemic infection; Combined with connective tissue disease; Known history of drug use; Known allergies or allergies to equipment materials; Creatinine > 2.5mg/dL or dialysis patients; Fungal or ruptured aneurysm; Known complications of thoracic aortic aneurysm require interventional treatment; American Association of Anesthesiologists (ASA) Grade V; Severe curvature or narrowing of the iliac and/or femoral arteries, resulting in difficulty in stent delivery.